BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1654206)

  • 1. Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice.
    Grant SG; Seidman I; Hanahan D; Bautch VL
    Cancer Res; 1991 Sep; 51(18):4917-23. PubMed ID: 1654206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
    Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
    Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and tumor progression in neuroendocrine digestive tumors.
    Poncet G; Villaume K; Walter T; Pourreyron C; Theillaumas A; Lépinasse F; Hervieu V; Cordier-Bussat M; Scoazec JY; Roche C
    J Surg Res; 2009 Jun; 154(1):68-77. PubMed ID: 18708196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.
    Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA
    Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
    Fujisawa T; Joshi B; Nakajima A; Puri RK
    Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice.
    Shi L; Itoh F; Itoh S; Takahashi S; Yamamoto M; Kato M
    Oncogene; 2008 May; 27(23):3265-73. PubMed ID: 18246128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
    Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.
    Perl AK; Dahl U; Wilgenbus P; Cremer H; Semb H; Christofori G
    Nat Med; 1999 Mar; 5(3):286-91. PubMed ID: 10086383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
    Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
    Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of pancreatic tumor metastasis in transgenic immunodeficient mice.
    Gallo-Hendrikx E; Copps J; Percy D; Croy BA; Wildeman AG
    Oncogene; 1994 Oct; 9(10):2983-90. PubMed ID: 8084602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes.
    Van Roy FM; Messiaen L; Liebaut G; Gao J; Dragonetti CH; Fiers WC; Mareel MM
    Cancer Res; 1986 Sep; 46(9):4787-95. PubMed ID: 3015398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
    Haddad R; Held WA
    Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.
    Buchholz M; Biebl A; Neesse A; Wagner M; Iwamura T; Leder G; Adler G; Gress TM
    Cancer Res; 2003 Aug; 63(16):4945-51. PubMed ID: 12941819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.